Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Mabs|June 4, 2010
Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allograftsJing Li, Bo Zhou, Jianzhong Shentu, et al.
Cancer Immunology, Immunotherapy : CII|March 16, 2007
Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FUSheng Hou, Geng Kou, Xiaoqiang Fan, et al.
Molecular Cancer Therapeutics|October 15, 2008
Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab') fragmentsJie Gao, Geng Kou, Huaiwen Chen, et al.
Gastroenterology|July 6, 2010
Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinomaBin Lu, Huaizu Guo, Jian Zhao, et al.
Biomaterials|February 8, 2011
The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomesJie Gao, Wei Liu, Yu Xia, et al.
Mabs|June 17, 2016
Acid-induced aggregation propensity of nivolumab is dependent on the FcBoning Liu, Huaizu Guo, Jin Xu, et al.
International Journal of Pharmaceutics|May 19, 2009
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomesJie Gao, Wei Zhong, Jinqiu He, et al.
Biochemical and Biophysical Research Communications|October 11, 2016
Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancerXi Chen, Jin Xu, Qingcheng Guo, et al.
Oncotarget|March 10, 2015
Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathwayLei Cao, Xiaoyu Fan, Wei Jing, et al.
Breast Cancer Research and Treatment|May 16, 2008
PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicityJie Gao, Geng Kou, Hao Wang, et al.
Pageof 22